drug
RYBREVANT FASPRO
updated 6mo agoby Janssen Biotech Inc
community read0 votes
🐶 often sniffed alongside
top 5all catalysts(0)
nothing on the calendar yet
News(1)
- FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell CarcinomaThe U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and n…fda_press · 13d ago
Data sources
last refreshed 6h ago
Found something off?
comments(0)
5-min edit window · permanent after that